The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy

Davide Tassinari, Luigi Montanari, Marco Maltoni, Michela Ballardini, Alessandra Piancastelli, Marco Musi, Giampiero Porzio, Vincenzo Minotti, Augusto Caraceni, Barbara Poggi, Anna Stella, Federica Aielli, Emanuela Scarpi

Research output: Contribution to journalArticle

Abstract

Purpose: To evaluate the accuracy of the Palliative Prognostic Score (PaP score) in selecting metastatic gastrointestinal or nonsmall-cell lung cancer patients candidate to palliative chemotherapy. Materials and methods: The PaP score was calculated in 173 patients with advanced, pretreated gastrointestinal or nonsmall-cell lung cancer before starting a further line of chemotherapy with palliative aim. Symptom distress score was calculated using the Edmonton Symptom Assessment System (ESAS) before every course of chemotherapy. Univariate analysis of survival was performed using the logrank test; multivariate analysis was performed using the Cox regression model. Symptom distress scores were compared using multivariate analysis of variance test for repeated measures, and overall symptom distress score was compared using analysis of variance test for repeated measures. Results: Overall median survival was 26 weeks; in PaP score class A it was 32 weeks, and in class B 8 weeks (p

Original languageEnglish
Pages (from-to)359-370
Number of pages12
JournalSupportive Care in Cancer
Volume16
Issue number4
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Drug Therapy
Non-Small Cell Lung Carcinoma
Survival
Analysis of Variance
Multivariate Analysis
Neoplasms
Symptom Assessment
Survival Analysis
Proportional Hazards Models

Keywords

  • Metastatic cancer
  • Nonsmall-cell lung cancer
  • Palliative prognostic score

ASJC Scopus subject areas

  • Oncology
  • Nursing(all)

Cite this

The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. / Tassinari, Davide; Montanari, Luigi; Maltoni, Marco; Ballardini, Michela; Piancastelli, Alessandra; Musi, Marco; Porzio, Giampiero; Minotti, Vincenzo; Caraceni, Augusto; Poggi, Barbara; Stella, Anna; Aielli, Federica; Scarpi, Emanuela.

In: Supportive Care in Cancer, Vol. 16, No. 4, 04.2008, p. 359-370.

Research output: Contribution to journalArticle

Tassinari, D, Montanari, L, Maltoni, M, Ballardini, M, Piancastelli, A, Musi, M, Porzio, G, Minotti, V, Caraceni, A, Poggi, B, Stella, A, Aielli, F & Scarpi, E 2008, 'The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy', Supportive Care in Cancer, vol. 16, no. 4, pp. 359-370. https://doi.org/10.1007/s00520-007-0302-3
Tassinari, Davide ; Montanari, Luigi ; Maltoni, Marco ; Ballardini, Michela ; Piancastelli, Alessandra ; Musi, Marco ; Porzio, Giampiero ; Minotti, Vincenzo ; Caraceni, Augusto ; Poggi, Barbara ; Stella, Anna ; Aielli, Federica ; Scarpi, Emanuela. / The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. In: Supportive Care in Cancer. 2008 ; Vol. 16, No. 4. pp. 359-370.
@article{428dcc875da64fb885d3e317cc24dfda,
title = "The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy",
abstract = "Purpose: To evaluate the accuracy of the Palliative Prognostic Score (PaP score) in selecting metastatic gastrointestinal or nonsmall-cell lung cancer patients candidate to palliative chemotherapy. Materials and methods: The PaP score was calculated in 173 patients with advanced, pretreated gastrointestinal or nonsmall-cell lung cancer before starting a further line of chemotherapy with palliative aim. Symptom distress score was calculated using the Edmonton Symptom Assessment System (ESAS) before every course of chemotherapy. Univariate analysis of survival was performed using the logrank test; multivariate analysis was performed using the Cox regression model. Symptom distress scores were compared using multivariate analysis of variance test for repeated measures, and overall symptom distress score was compared using analysis of variance test for repeated measures. Results: Overall median survival was 26 weeks; in PaP score class A it was 32 weeks, and in class B 8 weeks (p",
keywords = "Metastatic cancer, Nonsmall-cell lung cancer, Palliative prognostic score",
author = "Davide Tassinari and Luigi Montanari and Marco Maltoni and Michela Ballardini and Alessandra Piancastelli and Marco Musi and Giampiero Porzio and Vincenzo Minotti and Augusto Caraceni and Barbara Poggi and Anna Stella and Federica Aielli and Emanuela Scarpi",
year = "2008",
month = "4",
doi = "10.1007/s00520-007-0302-3",
language = "English",
volume = "16",
pages = "359--370",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy

AU - Tassinari, Davide

AU - Montanari, Luigi

AU - Maltoni, Marco

AU - Ballardini, Michela

AU - Piancastelli, Alessandra

AU - Musi, Marco

AU - Porzio, Giampiero

AU - Minotti, Vincenzo

AU - Caraceni, Augusto

AU - Poggi, Barbara

AU - Stella, Anna

AU - Aielli, Federica

AU - Scarpi, Emanuela

PY - 2008/4

Y1 - 2008/4

N2 - Purpose: To evaluate the accuracy of the Palliative Prognostic Score (PaP score) in selecting metastatic gastrointestinal or nonsmall-cell lung cancer patients candidate to palliative chemotherapy. Materials and methods: The PaP score was calculated in 173 patients with advanced, pretreated gastrointestinal or nonsmall-cell lung cancer before starting a further line of chemotherapy with palliative aim. Symptom distress score was calculated using the Edmonton Symptom Assessment System (ESAS) before every course of chemotherapy. Univariate analysis of survival was performed using the logrank test; multivariate analysis was performed using the Cox regression model. Symptom distress scores were compared using multivariate analysis of variance test for repeated measures, and overall symptom distress score was compared using analysis of variance test for repeated measures. Results: Overall median survival was 26 weeks; in PaP score class A it was 32 weeks, and in class B 8 weeks (p

AB - Purpose: To evaluate the accuracy of the Palliative Prognostic Score (PaP score) in selecting metastatic gastrointestinal or nonsmall-cell lung cancer patients candidate to palliative chemotherapy. Materials and methods: The PaP score was calculated in 173 patients with advanced, pretreated gastrointestinal or nonsmall-cell lung cancer before starting a further line of chemotherapy with palliative aim. Symptom distress score was calculated using the Edmonton Symptom Assessment System (ESAS) before every course of chemotherapy. Univariate analysis of survival was performed using the logrank test; multivariate analysis was performed using the Cox regression model. Symptom distress scores were compared using multivariate analysis of variance test for repeated measures, and overall symptom distress score was compared using analysis of variance test for repeated measures. Results: Overall median survival was 26 weeks; in PaP score class A it was 32 weeks, and in class B 8 weeks (p

KW - Metastatic cancer

KW - Nonsmall-cell lung cancer

KW - Palliative prognostic score

UR - http://www.scopus.com/inward/record.url?scp=43449115428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43449115428&partnerID=8YFLogxK

U2 - 10.1007/s00520-007-0302-3

DO - 10.1007/s00520-007-0302-3

M3 - Article

C2 - 17629751

AN - SCOPUS:43449115428

VL - 16

SP - 359

EP - 370

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 4

ER -